Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (692) 692
Book Chapter (12) 12
Patent (9) 9
Reference (8) 8
Book / eBook (2) 2
Conference Proceeding (2) 2
Newspaper Article (2) 2
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (391) 391
science & technology (371) 371
life sciences & biomedicine (368) 368
female (351) 351
oncology (319) 319
breast neoplasms - drug therapy (231) 231
breast cancer (197) 197
middle aged (194) 194
aged (179) 179
breast neoplasms - pathology (172) 172
adult (171) 171
biological and medical sciences (154) 154
medical sciences (153) 153
tumors (127) 127
chemotherapy (98) 98
treatment outcome (95) 95
antineoplastic combined chemotherapy protocols - therapeutic use (92) 92
gynecology. andrology. obstetrics (92) 92
mammary gland diseases (90) 90
cancer (78) 78
aged, 80 and over (70) 70
chemotherapy, adjuvant (70) 70
antineoplastic agents (67) 67
prognosis (66) 66
neoplasm staging (65) 65
pharmacology. drug treatments (60) 60
breast neoplasms - mortality (59) 59
antineoplastic combined chemotherapy protocols - adverse effects (58) 58
abridged index medicus (57) 57
breast neoplasms - metabolism (57) 57
breast neoplasms - surgery (56) 56
trastuzumab (54) 54
disease-free survival (52) 52
paclitaxel - administration & dosage (52) 52
risk factors (52) 52
care and treatment (49) 49
breast neoplasms - therapy (48) 48
receptor, erbb-2 - metabolism (47) 47
research (44) 44
breast neoplasms - genetics (43) 43
medicine & public health (43) 43
neoplasm metastasis (43) 43
drug administration schedule (41) 41
antineoplastic agents - therapeutic use (39) 39
dose-response relationship, drug (39) 39
health aspects (39) 39
follow-up studies (38) 38
retrospective studies (38) 38
cyclophosphamide - administration & dosage (37) 37
antineoplastic combined chemotherapy protocols - administration & dosage (36) 36
antibodies, monoclonal, humanized (32) 32
paclitaxel - adverse effects (32) 32
drug therapy (31) 31
time factors (31) 31
lymphatic metastasis (30) 30
survival analysis (30) 30
hematology, oncology and palliative medicine (29) 29
antineoplastic agents - adverse effects (28) 28
doxorubicin - administration & dosage (28) 28
mastectomy (28) 28
skin and connective tissue diseases (28) 28
clinical trials (26) 26
male (26) 26
united states (26) 26
metastasis (25) 25
original reports (25) 25
paclitaxel (25) 25
randomized controlled trials as topic (25) 25
receptor, erbb-2 - genetics (25) 25
combined modality therapy (24) 24
obesity (24) 24
risk assessment (24) 24
age factors (23) 23
surgery (23) 23
survival rate (23) 23
kaplan-meier estimate (22) 22
quality of life (22) 22
young adult (22) 22
animals (21) 21
antibodies, monoclonal - administration & dosage (21) 21
antineoplastic agents - administration & dosage (21) 21
adjuvant treatment (20) 20
antibodies, monoclonal, humanized - administration & dosage (20) 20
antineoplastic agents, hormonal - therapeutic use (19) 19
cyclophosphamide - adverse effects (19) 19
paclitaxel - therapeutic use (19) 19
receptors, estrogen - metabolism (19) 19
analysis (18) 18
bevacizumab (18) 18
breast neoplasms - chemistry (18) 18
clinical trials as topic (18) 18
fluorouracil - administration & dosage (18) 18
immunohistochemistry (18) 18
mice (18) 18
multiple tumors. solid tumors. tumors in childhood (18) 18
anthracyclines (17) 17
breast neoplasms - radiotherapy (17) 17
feasibility studies (17) 17
inflammation (17) 17
neoadjuvant therapy (17) 17
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Trastuzumab — Mechanism of Action and Use in Clinical Practice
by Hudis, Clifford A
The New England journal of medicine, ISSN 0028-4793, 07/2007, Volume 357, Issue 1, pp. 39 - 51
Biological and medical sciences | General aspects | Medical sciences | Antibodies, Monoclonal - pharmacology | Humans | Antibodies, Monoclonal - adverse effects | Receptor, ErbB-2 - metabolism | Antibodies, Monoclonal - therapeutic use | Antineoplastic Agents - therapeutic use | Breast Neoplasms - drug therapy | Breast Neoplasms - metabolism | Antibodies, Monoclonal, Humanized | Receptor, Epidermal Growth Factor - metabolism | Signal Transduction - drug effects | Antineoplastic Agents - adverse effects | Antineoplastic Agents - pharmacology | Receptor, ErbB-2 - immunology | Chemotherapy, Adjuvant | Receptor, ErbB-2 - analysis | Receptor, ErbB-2 - drug effects | Trastuzumab | Drug therapy | Breast cancer | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Triple‐Negative Breast Cancer: An Unmet Medical Need
by Hudis, Clifford A and Gianni, Luca
The oncologist (Dayton, Ohio), ISSN 1083-7159, 01/2011, Volume 16, Issue S1, pp. 1 - 11
Poly(ADP‐ribose) polymerase | Triple‐negative breast cancer | Basal‐like breast cancer | Chemotherapy | Epidermal growth factor receptor | Androgen receptor | Life Sciences & Biomedicine | Oncology | Science & Technology | Breast Neoplasms - therapy | Receptors, Estrogen - metabolism | Breast Neoplasms - genetics | Receptor, ErbB-2 - genetics | Breast Neoplasms - pathology | Humans | Receptor, ErbB-2 - metabolism | Female | Breast Neoplasms - metabolism | Receptors, Progesterone - metabolism | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Biology before Anatomy in Early Breast Cancer — Precisely the Point
by Hudis, Clifford A
The New England journal of medicine, ISSN 0028-4793, 11/2015, Volume 373, Issue 21, pp. 2079 - 2080
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Female | Breast Neoplasms - genetics | Neoplasm Recurrence, Local - prevention & control | Breast Neoplasms - drug therapy | Antineoplastic Agents, Hormonal - therapeutic use | Humans | Care and treatment | Chemotherapy | Usage | Breast cancer | Management | Public health | Cancer | Standardization | Clinical trials | Metastases | Tumors | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Obesity and Cancer: Local and Systemic Mechanisms
by Iyengar, Neil M and Hudis, Clifford A and Dannenberg, Andrew J
Annual review of medicine, ISSN 0066-4219, 1/2015, Volume 66, Issue 1, pp. 297 - 309
metabolic syndrome | macrophages | inflammation | body mass index | cancer risk | adipose tissue | insulin resistance | adipocytes | Neoplasms - metabolism | Cytokines - metabolism | Humans | Insulin Resistance | Lipid Metabolism | Adipokines - metabolism | Obesity - metabolism | Adipose Tissue - metabolism | Inflammation - metabolism | Insulin - metabolism | Androgens - metabolism | Estrogens - metabolism | Insulin-Like Growth Factor I - metabolism | Obesity | Complications and side effects | Research | Oncology, Experimental | Cancer | Correlation analysis | Medical prognosis | Risk factors | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Increasing Precision in Adjuvant Therapy for Breast Cancer
by Hudis, Clifford A and Dickler, Maura
The New England journal of medicine, ISSN 0028-4793, 08/2016, Volume 375, Issue 8, pp. 790 - 791
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Humans | Tamoxifen - therapeutic use | Neoplasm Recurrence, Local - drug therapy | Combined Modality Therapy | Chemotherapy, Adjuvant | Breast Neoplasms - drug therapy | Care and treatment | Usage | Breast cancer | Diagnosis | Adjuvant treatment | Cancer | Chemotherapy | Cytotoxicity | Genetic testing | Metastasis | Patients | Tumors | Metastases | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial
by Albain, Kathy S, Prof and Barlow, William E, Prof and Shak, Steven, MD and Hortobagyi, Gabriel N, Prof and Livingston, Robert B, Prof and Yeh, I-Tien, Prof and Ravdin, Peter, Prof and Bugarini, Roberto, DStat and Baehner, Frederick L, MD and Davidson, Nancy E, Prof and Sledge, George W, Prof and Winer, Eric P, Prof and Hudis, Clifford, Prof and Ingle, James N, Prof and Perez, Edith A, Prof and Pritchard, Kathleen I, Prof and Shepherd, Lois, Prof and Gralow, Julie R, Prof and Yoshizawa, Carl, PhD and Allred, D Craig, Prof and Osborne, C Kent, Prof and Hayes, Daniel F, Prof and for The Breast Cancer Intergroup of North America and Breast Canc Intergrp N Amer and Breast Cancer Intergroup of North America
The lancet oncology, ISSN 1470-2045, 2010, Volume 11, Issue 1, pp. 55 - 65
Hematology, Oncology and Palliative Medicine | Life Sciences & Biomedicine | Oncology | Science & Technology | Doxorubicin - therapeutic use | Predictive Value of Tests | Recurrence | United States - epidemiology | Breast Neoplasms - secondary | Humans | Middle Aged | Gene Expression Regulation, Neoplastic | Gene Expression Profiling | Receptors, Estrogen - analysis | Genetic Testing - methods | Cyclophosphamide - therapeutic use | Patient Selection | Fluorouracil - therapeutic use | Breast Neoplasms - chemistry | Clinical Trials, Phase III as Topic | Time Factors | Postmenopause | Adult | Female | Retrospective Studies | Risk Assessment | Kaplan-Meier Estimate | Proportional Hazards Models | Treatment Outcome | Lymphatic Metastasis | Reverse Transcriptase Polymerase Chain Reaction | Breast Neoplasms - drug therapy | Randomized Controlled Trials as Topic | Disease-Free Survival | Breast Neoplasms - genetics | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Tamoxifen - therapeutic use | Breast Neoplasms - mortality | Aged | Biomarkers, Tumor - genetics | Chemotherapy | Cyclophosphamide | Clinical trials | genomics | Breast cancer | Tamoxifen | Doxorubicin | Survival | Nodes | Post-menopause | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Lumpectomy Plus Tamoxifen With or Without Irradiation in Women Age 70 Years or Older With Early Breast Cancer: Long-Term Follow-Up of CALGB 9343
by Kevin S. Hughes and Lauren A. Schnaper and Jennifer R. Bellon and Constance T. Cirrincione and Donald A. Berry and Beryl McCormick and Hyman B. Muss and Barbara L. Smith and Clifford A. Hudis and Eric P. Winer and William C. Wood
Journal of clinical oncology, ISSN 0732-183X, 07/2013, Volume 31, Issue 19, pp. 2382 - 2387
Life Sciences & Biomedicine | Oncology | Science & Technology | Gynecology. Andrology. Obstetrics | Mammary gland diseases | Biological and medical sciences | Multiple tumors. Solid tumors. Tumors in childhood (general aspects) | Medical sciences | Tumors | Breast Neoplasms - surgery | Follow-Up Studies | Neoplasm Recurrence, Local - prevention & control | Biomarkers, Tumor - analysis | Humans | Kaplan-Meier Estimate | Treatment Outcome | Receptors, Estrogen - analysis | Breast Neoplasms - drug therapy | Breast Neoplasms - therapy | Breast Neoplasms - chemistry | Time Factors | Breast Neoplasms - pathology | Mastectomy, Segmental | Antineoplastic Agents, Hormonal - therapeutic use | Tamoxifen - therapeutic use | Aged, 80 and over | Breast Neoplasms - mortality | Female | Aged | Neoplasm Staging | Odds Ratio | Radiotherapy, Adjuvant - utilization | Index Medicus | Bc4 | Bc3 | Bc6 | ORIGINAL REPORTS | Bc7
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Overall survival results of a trial assessing patient-reported outcomes for symptom monitoring during routine cancer treatment
by Basch, Ethan and Deal, Allison M and Dueck, Amylou C and Scher, Howard I and Kris, Mark G and Hudis, Clifford and Schrag, Deborah
JAMA : the journal of the American Medical Association, ISSN 0098-7484, 07/2017, Volume 318, Issue 2, pp. 197 - 198
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Follow-Up Studies | Humans | Middle Aged | Symptom Assessment | Neoplasms - mortality | Male | Randomized Controlled Trials as Topic | Neoplasms - complications | Neoplasm Metastasis | Neoplasms - therapy | Survival Analysis | Aged, 80 and over | Quality of Life | Adult | Female | Aged | Patient Reported Outcome Measures
Journal Article
Details down arrow
9. Full Text Drug therapy: Trastuzumab - Mechanism of action and use in clinical practice
by Hudis, Clifford A
The New England journal of medicine, ISSN 0028-4793, 07/2007, Volume 357, Issue 1, pp. 39 - 51
Life Sciences & Biomedicine | Medicine, General & Internal | General & Internal Medicine | Science & Technology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text ESR1 ligand-binding domain mutations in hormone-resistant breast cancer
by Toy, Weiyi and Shen, Yang and Won, Helen and Green, Bradley and Sakr, Rita A and Will, Marie and Li, Zhiqiang and Gala, Kinisha and Fanning, Sean and King, Tari A and Hudis, Clifford and Chen, David and Taran, Tetiana and Hortobagyi, Gabriel and Greene, Geoffrey and Berger, Michael and Baselga, José and Chandarlapaty, Sarat
Nature genetics, ISSN 1061-4036, 12/2013, Volume 45, Issue 12, pp. 1439 - 1445
Life Sciences & Biomedicine | Genetics & Heredity | Science & Technology | Estrogen Receptor alpha - chemistry | Humans | Models, Molecular | Mutation, Missense | Breast Neoplasms - drug therapy | Drug Resistance, Neoplasm - genetics | Animals | Estrogen Receptor alpha - genetics | Estrogen Antagonists - therapeutic use | MCF-7 Cells | Mice, Nude | Protein Interaction Domains and Motifs - genetics | Antineoplastic Agents, Hormonal - therapeutic use | Cell Line, Tumor | Estrogen Receptor alpha - metabolism | Female | Ligands | Mice | Mice, Inbred BALB C | Estrogens - metabolism | Receptors | Gene mutations | Estrogen | Breast cancer | Genetic aspects | Drug resistance | Identification and classification | Studies | Medical research | Clinical trials | Genomes | Mutation | Gene expression | Cancer therapies | Deoxyribonucleic acid--DNA | Tumors | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text MONARCH 1, A Phase II Study of Abemaciclib, a CDK4 and CDK6 Inhibitor, as a Single Agent, in Patients with Refractory HR+/HER2(-) Metastatic Breast Cancer
by Dickler, Maura N and Tolaney, Sara M and Rugo, Hope S and Cortes, Javier and Dieras, Veronique and Patt, Debra and Wildiers, Hans and Hudis, Clifford A and O'Shaughnessy, Joyce and Zamora, Esther and Yardley, Denise A and Frenzel, Martin and Koustenis, Andrew and Baselga, Jose
Clinical cancer research, ISSN 1078-0432, 09/2017, Volume 23, Issue 17, pp. 5218 - 5224
Life Sciences & Biomedicine | Oncology | Science & Technology | Cyclin-Dependent Kinase 6 - antagonists & inhibitors | Aminopyridines - administration & dosage | Prognosis | Receptor, ErbB-2 - genetics | Cyclin-Dependent Kinase 4 - genetics | Humans | Middle Aged | Cyclin-Dependent Kinase 6 - genetics | Aminopyridines - adverse effects | Treatment Outcome | Breast Neoplasms - drug therapy | Drug-Related Side Effects and Adverse Reactions - pathology | Disease-Free Survival | Neoplasm Metastasis | Breast Neoplasms - genetics | Benzimidazoles - administration & dosage | Breast Neoplasms - pathology | Aged, 80 and over | Adult | Female | Aged | Benzimidazoles - adverse effects | Cyclin-Dependent Kinase 4 - antagonists & inhibitors | Drug-Related Side Effects and Adverse Reactions - classification | Toxicity | Diarrhea | Fatigue | Nausea | Breast cancer | Metastasis | Cancer therapies | Patients | Survival | ErbB-2 protein | Cyclin-dependent kinase 4 | Metastases | Chemotherapy | Inhibitors | Experimental design | Quality | Medical prognosis | Response rates | Toxic diseases | Cancer | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights